Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  'Xgeva'  -  Page 2
Latest

Amgen reacquires rights to sell 3 drugs worldwide

By   /  Monday, December 14th, 2015  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Amgen reacquires rights to sell 3 drugs worldwide

Amgen reacquired all rights to sell three drugs worldwide on Dec. 14. The Thousand Oaks-based biotech giant said it reacquired the rights to Prolia, Vectibix and Xgeva in 48 ccountries from British pharmaceutical company GlaxoSmithKline. The agreement includes large countries like Australia, China and Brazil. Prolia is designed to raise bone density in people with Read More →

Read More →
Latest

Amgen expects approval for Xgeva as bone treatment in April

By   /  Monday, August 22nd, 2011  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen expects approval for Xgeva as bone treatment in April

Thousand Oaks-based Amgen said Aug. 22 that the U.S. Food and Drug Administration will likely make a decision by April 26, 2012 on the biotech firm’s application to expand the use of its Xgeva bone treatment drug to treat advanced prostate cancer. Amgen, the largest biotech company in the world, said in a statement that Read More →

Read More →